4//SEC Filing
Shanmugam Muthusamy 4
Accession 0001870913-24-000028
CIK 0001023024other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 5:30 PM ET
Size
7.0 KB
Accession
0001870913-24-000028
Insider Transaction Report
Form 4
Shanmugam Muthusamy
DirectorHEAD OF R&D, COO-NOVITIUM OPS
Transactions
- Sale
Common Stock
2024-07-18$62.00/sh−2,743$170,066→ 632,620 total(indirect: By LLC)
Holdings
- 5,000(indirect: By LLC)
Common Stock
- 68,652
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023.
- [F2]The shares were sold in multiple trades at prices ranging from $61.01 to $62.92. The price reported above reflects the weighted average sales price.
- [F3]The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- [F4]The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001870913
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 5:30 PM ET
- Size
- 7.0 KB